Literature DB >> 14694459

Acupuncture reflexotherapy in the treatment of sensory urgency that persists after transurethral resection of the prostate: a preliminary report.

Luigi Ricci1, Daniele Minardi, Marco Romoli, Andrea B Galosi, Giovanni Muzzonigro.   

Abstract

AIMS: In this study, we wanted to evaluate whether acupuncture reflexotherapy is able to treat the sensory irritative components of LUTS (lower urinary tract symptoms) that persist after transurethral resection of the prostate.
METHODS: We have evaluated 42 patients, randomly selected into three groups: 14 patients received placebo, 15 patients received oxybutynin, and 13 patient were treated with electrostimulation by acupuncture reflexotherapy.
RESULTS: Before treatment, the mean maximum flow rate (Qmax) was 21.0 +/- 3.2 mL/sec, the mean International Prostate Symptom Score (I-PSS) score was 12.9 +/- 4.2, the mean I-PSS Quality of Life (IPSS QoL) score was 3.6 +/- 1.2. At the first check-up performed after 3 months, we could observe that the I-PSS and QoL scores were 12.6 +/- 4.3 and 3.8 +/- 1.3 in the group who received placebo; the scores decreased to 11.1 +/- 3.2 and to 3.1 +/- 1.0, respectively, in the 15 patients treated with oxybutynin and decreased to 6.1 +/- 2.6 and 1.3 +/- 1.1, respectively, in the 13 patients who underwent acupuncture reflexotherapy. At 1-year follow-up, these parameters were practically similar. The voiding diaries allowed us to deduce that the average number of daytime voidings decreased by 8% in patients who received oxybutynin and decreased by 20% in 13 patients who underwent reflexotherapy; the average number of nocturnal micturitions decreased by approximately 20% and 60%, respectively, in patients who received oxybutynin and reflexotherapy.
CONCLUSIONS: This study has pointed out that acupuncture reflexotherapy has a real benefit in patients with sensory urgency that persists after transurethral resection of the prostate. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694459     DOI: 10.1002/nau.10105

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  7 in total

Review 1.  Conservative management for postprostatectomy urinary incontinence.

Authors:  Coral A Anderson; Muhammad Imran Omar; Susan E Campbell; Kathleen F Hunter; June D Cody; Cathryn M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

2.  Complementary therapies in the control of male lower urinary tract symptoms: A systematic review.

Authors:  Luciana Regina Ferreira da Mata; Paula Giuliana Rodrigues Motter; Cissa Azevedo; Mariana Ferreira Vaz Gontijo Bernardes; Tânia Couto Machado Chianca; Christiane Inocêncio Vasques
Journal:  Rev Lat Am Enfermagem       Date:  2022-07-15

Review 3.  Electrical stimulation with non-implanted electrodes for overactive bladder in adults.

Authors:  Fiona Stewart; Luis F Gameiro; Regina El Dib; Monica O Gameiro; Anil Kapoor; Joao L Amaro
Journal:  Cochrane Database Syst Rev       Date:  2016-12-09

4.  Effects of electroacupuncture on benign prostate hyperplasia patients with lower urinary tract symptoms: a single-blinded, randomized controlled trial.

Authors:  Jung-Sheng Yu; Kun-Hung Shen; Wen-Chi Chen; Jiann-Shyan Her; Ching-Liang Hsieh
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-13       Impact factor: 2.629

Review 5.  Prevalence, Burden, and Treatment of Lower Urinary Tract Symptoms in Men Aged 50 and Older: A Systematic Review of the Literature.

Authors:  Amy Y Zhang; Xinyi Xu
Journal:  SAGE Open Nurs       Date:  2018-12-26

6.  Prospective tests on biological models of acupuncture.

Authors:  Charles Shang
Journal:  Evid Based Complement Alternat Med       Date:  2007-11-21       Impact factor: 2.629

7.  Electroacupuncture for moderate and severe benign prostatic hyperplasia: a randomized controlled trial.

Authors:  Yang Wang; Baoyan Liu; Jinna Yu; Jiani Wu; Jing Wang; Zhishun Liu
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.